Literature DB >> 23775076

The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.

Shannon P Fortin Ensign1, Ian T Mathews, Jennifer M Eschbacher, Joseph C Loftus, Marc H Symons, Nhan L Tran.   

Abstract

Glioblastoma (GB) is the highest grade of primary adult brain tumors, characterized by a poorly defined and highly invasive cell population. Importantly, these invading cells are attributed with having a decreased sensitivity to radiation and chemotherapy. TNF-like weak inducer of apoptosis (TWEAK)-Fn14 ligand-receptor signaling is one mechanism in GB that promotes cell invasiveness and survival and is dependent upon the activity of multiple Rho GTPases, including Rac1. Here we report that Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF), a RhoG-specific guanine nucleotide exchange factor, is overexpressed in GB tumors and promotes TWEAK-Fn14-mediated glioma invasion. Importantly, levels of SGEF expression in GB tumors inversely correlate with patient survival. SGEF mRNA expression is increased in GB cells at the invasive rim relative to those in the tumor core, and knockdown of SGEF expression by shRNA decreases glioma cell migration in vitro and invasion ex vivo. Furthermore, we showed that, upon TWEAK stimulation, SGEF is recruited to the Fn14 cytoplasmic tail via TRAF2. Mutation of the Fn14-TRAF domain site or depletion of TNF receptor-associated factor 2 (TRAF2) expression by siRNA oligonucleotides blocked SGEF recruitment to Fn14 and inhibited SGEF activity and subsequent GB cell migration. We also showed that knockdown of either SGEF or RhoG diminished TWEAK activation of Rac1 and subsequent lamellipodia formation. Together, these results indicate that SGEF-RhoG is an important downstream regulator of TWEAK-Fn14-driven GB cell migration and invasion.

Entities:  

Keywords:  Cell Invasion; Cell Signaling; Glioblastoma; Guanine Nucleotide Exchange Factor (GEF); Rho GTPases

Mesh:

Substances:

Year:  2013        PMID: 23775076      PMCID: PMC3724644          DOI: 10.1074/jbc.M113.468686

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  RhoG signals in parallel with Rac1 and Cdc42.

Authors:  Krister Wennerberg; Shawn M Ellerbroek; Rong-Yu Liu; Antoine E Karnoub; Keith Burridge; Channing J Der
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

2.  Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.

Authors:  Jean-François Côté; Kristiina Vuori
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

3.  Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex.

Authors:  Enrico Brugnera; Lisa Haney; Cynthia Grimsley; Mingjian Lu; Scott F Walk; Annie-Carole Tosello-Trampont; Ian G Macara; Hiten Madhani; Gerald R Fink; Kodimangalam S Ravichandran
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

4.  RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo.

Authors:  Hironori Katoh; Manabu Negishi
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

5.  Structural basis for the signaling specificity of RhoG and Rac1 GTPases.

Authors:  Rosario M Prieto-Sánchez; Xosé R Bustelo
Journal:  J Biol Chem       Date:  2003-06-12       Impact factor: 5.157

6.  Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis.

Authors:  L Mariani; C Beaudry; W S McDonough; D B Hoelzinger; T Demuth; K R Ross; T Berens; S W Coons; G Watts; J M Trent; J S Wei; A Giese; M E Berens
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

7.  The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells.

Authors:  Mitsutoshi Nakada; Jared A Niska; Hisashi Miyamori; Wendy S McDonough; Jie Wu; Hiroshi Sato; Michael E Berens
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

8.  The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.

Authors:  Sharron A N Brown; Christine M Richards; Heather N Hanscom; Sheau-Line Y Feng; Jeffrey A Winkles
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

9.  The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors.

Authors:  Nhan L Tran; Wendy S McDonough; Patrick J Donohue; Jeffrey A Winkles; Theresa J Berens; Kristen R Ross; Dominique B Hoelzinger; Christian Beaudry; Stephen W Coons; Michael E Berens
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in non-small cell lung cancer cells.

Authors:  Hee Jung Yang; HyeSook Youn; Ki Moon Seong; Young-Woo Jin; Joon Kim; BuHyun Youn
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

View more
  21 in total

1.  FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion.

Authors:  Timothy G Whitsett; Shannon P Fortin Ensign; Harshil D Dhruv; Landon J Inge; Paul Kurywchak; Kerri K Wolf; Janine LoBello; Christopher B Kingsley; Jeffrey W Allen; Glen J Weiss; Nhan L Tran
Journal:  Clin Exp Metastasis       Date:  2014-04-08       Impact factor: 5.150

2.  A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells.

Authors:  Silvia M Goicoechea; Ashtyn Zinn; Sahezeel S Awadia; Kyle Snyder; Rafael Garcia-Mata
Journal:  J Cell Sci       Date:  2017-02-15       Impact factor: 5.285

3.  Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.

Authors:  Timothy G Whitsett; Ian T Mathews; Michael H Cardone; Ryan J Lena; William E Pierceall; Michael Bittner; Chao Sima; Janine LoBello; Glen J Weiss; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2014-01-27       Impact factor: 5.852

Review 4.  The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.

Authors:  J G Perez; N L Tran; M G Rosenblum; C S Schneider; N P Connolly; A J Kim; G F Woodworth; J A Winkles
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

5.  SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.

Authors:  Shannon P Fortin Ensign; Alison Roos; Ian T Mathews; Harshil D Dhruv; Serdar Tuncali; Jann N Sarkaria; Marc H Symons; Joseph C Loftus; Michael E Berens; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2016-01-13       Impact factor: 5.852

6.  Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.

Authors:  Harshil D Dhruv; Alison Roos; Patrick J Tomboc; Serdar Tuncali; Ashley Chavez; Ian Mathews; Michael E Berens; Joseph C Loftus; Nhan L Tran
Journal:  J Neurooncol       Date:  2015-11-12       Impact factor: 4.130

7.  TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK.

Authors:  José Antonio Carmona Arana; Axel Seher; Manfred Neumann; Isabell Lang; Daniela Siegmund; Harald Wajant
Journal:  Front Immunol       Date:  2014-02-18       Impact factor: 7.561

8.  Tyrosine Phosphorylation of SGEF Regulates RhoG Activity and Cell Migration.

Authors:  Yusuke Okuyama; Kentaro Umeda; Manabu Negishi; Hironori Katoh
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

Review 9.  Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.

Authors:  Shannon Patricia Fortin Ensign; Ian T Mathews; Marc H Symons; Michael E Berens; Nhan L Tran
Journal:  Front Oncol       Date:  2013-10-04       Impact factor: 6.244

10.  Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.

Authors:  D W Murray; S Didier; A Chan; V Paulino; L Van Aelst; R Ruggieri; N L Tran; A T Byrne; M Symons
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.